Latin American Equity Research. Alfa Agrees to Sell Hylsamex and Sidor Stakes to Techint

Size: px
Start display at page:

Download "Latin American Equity Research. Alfa Agrees to Sell Hylsamex and Sidor Stakes to Techint"

Transcription

1 Latin American Equity Research Mexico, May 19, 2005 ALFA Flashnote Mexico Conglomerates STRONG BUY Alfa Agrees to Sell Hylsamex and Sidor Stakes to Techint Luis Miranda, CFA (5255) (05/18/2005) CURRENT PRICE: US$5.62/M$61.78 TARGET PRICE: US$6.15/M$73.00 News Alfa announced that it had accepted an offer from Techint to purchase Alfa 42.5% stake in Hylsamex. The offer will be extended to all of Hylsamex s shareholders and will consist of a US$2,253 million offer (approximately US$3.71 per share) and a US$143 million extraordinary dividend (approximately US$0.24 per share). Company Statistics Bloomberg ALFAA MM 52-Week Range (US$) US$3.12-US$ E P/E Rel to IPC (x) E P/E Rel to Congs. (x) 1.7 IPC (US$) 1,162 3-Yr CAGR (04-07E) 28.2% Market Capitalization (US$ Mn) US$3,278 Float (%) 35% 3-Mth Avg Daily Vol (US$000) 8,230 Shares Outst (ADR NA) 581 Net Debt/Equity (x) 0.5 Book Value per Share (US$) 3.99 Estimates and Valuation Ratios E 2006E Net Earn (M$ bn)) 979 4,350 2,006 1,622 Current EPS Net Earn (US$ mn) Current EPADR P/E (x) P/Sales (x) P/CE (x) FV/EBITDA (x) FV/Sales (x) FCF Yield (%) 18% 31% 14% 7% Div per ADR (US$) Div Yield (%) 4.0% 2.0% 1.4% 1.4% Sources: Bloomberg, Company Reports and Santander Investment estimates. News/Analysis: On May 18, Alfa announced it had accepted an offer from Grupo Techint to purchase its 42.5% stake in Hylsamex. Pursuant to the agreement with Techint, the offer will be extended to all of Hylsamex s series B and L shareholders, conditioned on acceptance by the holders of a majority of all of Hylsamex s outstanding shares. The board of directors of Hylsamex approved the US$2,253 million offer, which is for 100% of the shares (approximately US$3.71 per share, or M$40.80 at M$11.00/US$, which is 5.7% higher than current levels). This would be a public tender offer for Hylsamex shares in an amount equal to US$2,110 million (US$3.47 per share, or M$30.17 per share), with an extraordinary dividend to all shareholders in the amount of US$143 million (M$2.59 per share). Techint also agreed to buy Alfa s 4.5% stake in Sidor for approximately US$107 million. The offers will be made in U.S. dollars and paid in pesos at the exchange rate prevailing on the date of the closing of the transaction. The estimated time for the process is 90 days. Net/Net: We regard this news as very positive for Alfa s stock, believe its effects are not priced in, and reiterate our Strong Buy rating. Due to the limited upside potential for Hylsamex s shares from current levels, we believe that Alfa is the way to play the upside potential in this operation, and thus we recommend a switch from Hylsamex to Alfa. If the transaction is approved, Alfa would receive close to US$1,065 million: US$897 million from the tender offer, US$US$61 million from the dividend, and US$107 million from its stake in Sidor. This represents 86% of Alfa s net debt as of March 2005 and would be used to reduce debt and consider dividend payments and future share buy-back programs. Considering the cash effect of the proceeds, we estimate that Alfa s FV/EBITDA valuation would improve from 7.4x in 2005 to 5.1x, a 31% improvement and a 7% discount to its 5.5x five-year average and a 15% discount to its peers. In terms of NAV, we believe Alfa s discount could widen from 14% to approximately 32%. Valuation and Risks to Investment Thesis: Our year-end 2005 target price of US$6.15 for Alfa is based on an FV/EBITDA multiple of 6.1x, in line with Alfa s average in the period (prior to its highleverage and weak results period). We also used our NAV model as a cross reference The main risks to our investment thesis: (1) higher-thanexpected margin pressure on Alpek and Sigma due to higher cost of raw materials; (2) high exposure to U.S. OEMs; and (3) lower-than-expected economic growth in the U.S. and Mexico. 1

2 Alfa: Agrees to Sell Hylsamex and Sidor Stakes to Techint. ALFA S VALUATION The sale of Alfa s 42.5% stake in Hylsamex, the proportional cash from the dividend, and the US$107 million from Sidor, represent US$ million, or 89% of Alfa s consolidated net debt as of March We believe this is one of the most attractive attributes of the potential transaction: it would be a plain-vanilla, all-cash deal. Management stated in the company s the press release that proceeds would be used to: reduce debt, in order to achieve a capital structure that provides greater flexibility to pursue attractive investment opportunities, as well as to consider dividends for shareholders or a future share repurchase program. No specific amount or distribution was disclosed, but all three options would be accretive for shareholders. Considering the first and full impact of the operations, we estimate that our 2005 EV/EBITDA estimate for Alfa of 7.4 times would improve to 5.1 times, if all the cash were to be used to pay down debt. This would take Alfa to attractive valuation levels, in our view, allowing it to trade at only a 7% discount to its five-year average and only 15% discount to its peers (considering 2005 FV/EBITDA). The following graph shows Alfa s forward-looking FV/EBITDA, with its five-year average and plus and minus one and two standard deviations as a reference. Figure 1. Alfa Forward FV/EBITDA with Five-Year Average and +/- 1 Std. Deviation) A lfa's new 2005 FV /EBITDA multiple w ith 100% of cash used to pay dow n debt. J-00 M-00 J-00 S-00 D-00 M-01 J-01 S-01 N-01 F-02 M-02 A-02 O-02 J-03 A-03 J-03 S-03 D-03 M-04 J-04 A-04 N-04 F-05 M-05 Sources: Company reports and Santander Investment Securities estimates. BASIC SCENARIOS However, we do not believe that Alfa would use all the cash to pay down debt, as Alfa already has a solid financial structure, with interest coverage of 8.4 times and net debt/2005e EBITDA of 1.7 times (as of 1Q05). We believe that once the deal is over and Alfa receives the cash, there be a distribution of resources among the three different options, with the share buy-back program, in our opinion, being the least probable in the medium term. Figure 2 shows three basic scenarios that we believe indicate what the impact would be of the different uses of the proceeds (US$1,65 million): paying down debt, distributing a dividend, or buying back shares. Figure 2. Alfa Basic Scenarios for Uses of Proceeds from Hylsamex s Divestiture Debt Reduction 100% 60% 40% Net Debt (US$ Million) US$170 US$596 US$809 FV/EBITDA 2005E Dividend (% of Proceeds)t 0% 40% 30% US$/Share Yield - 13% 10% Buyback 0% 0% 30% % Share Outstanding % Source: Santander Investment Estimates. 2

3 KEY MILESTONES Alfa s management believes the process could take approximately 90 days to be finalized (by the second half of August). The main milestones would be: - Approval from the Antitrust Commission. - Approval from stock exchange authority (CNBV) for the tender offer. - Tender offer for 100% of Hylsamex B and L shares. - Approval of the offer by Hylsamex s stockholders. - Extraordinary shareholder meeting to approve Hylsamex s US$143 million dividend for shareholders.. - Payment of dividends. - Settlement of tender offer. CONSORCIO SIDERURGIA AMAZONIA LTD. Consorcio Siderurgia Amazonia (Amazonia), owns 59.7% of the integrated Venezuelan steel company Sidor, with the other 40.3% owned by the Venezuelan government. The shareholders of Amazonia are Techint (25.0%), Tenaris (21.2%), Usiminas (16.6%), Siderar (14.4%), Hylsamex (12.0%), Alfa (7.5%), and Sivensa (3.4%). Teching agreed to buy Alfa s effective 4.5% stake in Sidor for approximately US$107 million. Alfa invested directly in Amazonia US$97 million (US$82 million in 1999 and US$15 million in 2003). Tenaris would exchange is share in Sidor for a stake in a new company that would hold the Techint stakes in Siderar, Hylsamex and Sidor. SOME KEY POINTS THAT STILL NEED TO BE CLEARED UP Alfa. How will the cash be used? We believe the main driver will be management s objective for Alfa s long-term financial structure relative to its net debt to EBITDA and interest coverage. Alfa. When the cash is received, will this speed up the Sigma s expansion program? If so, will management focus more on the U.S. effort or on Central America? Alfa. Have all the due-diligence process been completed? Is there more time needed for due diligence and would that affect the amount to be paid by Techint. And, are there another factors that could affect the amount? Techint. Will the shares of NEWCO, holder of Techint s stake in Siderar, Sidor,and Hylsamex be listed in Mexico in the medium term and in other markets, as well. Could this be the way for some investors to hold a regional steel play. Patrick Conrad, our Steel and Mining analyst in Brazil, believes that is important to clarify the following points. First, what happens to the 9.9% participation (16.6% of Consorcio Amazonia, which owns 59.7% stake at Sidor) that Usiminas holds in Sidor and its 5.3% participation at Siderar? Usiminas stated in its 1Q05 results conference call this week that it intends to hold on to its participation in Sidor and Siderar and had no intention of selling its positions or adding to them. We wonder if at some point Tenaris would also be offered a stake in the NEWCO in exchange for Usiminas's participation in Sidor and Siderar. Second, the market was speculating that Gerdau was a potential buyer for Hylsamex s long-steel division. Would a sale of Hylsamex to Techint be negative for Gerdau? In our view, Hylsamex was a possible way for Gerdau to supply long-steel products to the West Coast of the U.S.; however the concerns about Gerdau overpaying for an acquisition at the peak of the cycle (or close to it) also existed. With the sale to Techint, the latter is no longer a concern. However, we will have to follow up on Gerdau s strategy in the U.S. market. 3

4 Alfa: Agrees to Sell Hylsamex and Sidor Stakes to Techint IMPORTANT DISCLOSURES Alfa Three-Year Stock Performance (U.S. Dollars) Dropped Coverage 1/3/ M-02 J-02 S-02 D-02 M-03 J-03 S-03 D-03 M-04 J-04 S-04 D-04 M-05 Alfa (L Axis) B $3.70 1/13/04* B $4.05 1/20/04 B $4.20 3/31/04 IPC (R Axis) SB $6.15 3/10/05 SB $4.30 9/24/04 1,300 1,200 1,100 1, Analyst Recommendations and Price Objectives SB: Strong Buy B: Buy H: Hold UP: Underperform S: Sell UR: Under Review Source: Santander Investment. 4

5 Key to Investment Codes Rating IMPORTANT DISCLOSURES (DISCONTINUED) Definition % of Companies Covered with This Rating % of Companies Provided Investment Banking Services in the Past 12 Months Strong Buy Expected to outperform the local market more than 15% % 73.33% Buy Expected to outperform the local market 5%-15%. Hold Expected to perform within a range of 5% above or below the local market % 13.33% Underperform Expected to underperform the local market 5%-15% % -- Sell Expected to underperform the local market more than 15%. Under Review 10.43% 13.33% The numbers above reflect our Latin American universe. For a discussion, if applicable, of the valuation methods used to determine the price targets included in this report and the risks to achieving these targets, please refer to the latest published research on these stocks. Research is available through your sales representative and other electronic systems. Target prices are 2005 year-end unless otherwise specified. Recommendations are based on a total return basis (expected share price appreciation + prospective dividend yield) unless otherwise specified. Stock price charts and rating histories for companies discussed in this report are also available by written request to Santander Investment Securities Inc., 45 East 53 rd Street, 17 th Floor (Attn: Research Disclosures), New York, NY USA. Ratings are established when the firm sets a target price and/or when maintaining or reiterating the rating. Ratings may not coincide with the above methodology due to price volatility. Management reserves the right to maintain or to modify ratings on any specific stock and will disclose this in the report when it occurs. Valuation methodologies vary from stock to stock, analyst to analyst, and country to country. Any investment in Latin American equities is, by its nature, risky. A full discussion of valuation methodology and risks related to achieving the target price of the subject security is included in the body of this report. The benchmark used for establishing Argentina recommendations is our forecast of the year-end Argentina IFCI index. For the Andean countries, our benchmark is the simple average of the country risk of each country plus the 10 year U.S. T-Bond yield plus 5.5% of equity risk premium. For additional information about our rating methodology, please call (212) This report has been prepared by Santander Investment Securities Inc. ( SIS ) (a subsidiary of Santander Investment S.A., which is wholly owned by Banco Santander Central Hispano, S.A. ("Santander"), on behalf of itself and its affiliates (collectively, Grupo Santander) and is provided for information purposes only. This document must not be considered as an offer to sell or a solicitation of an offer to buy any relevant securities (i.e., securities mentioned herein or of the same issuer and/or options, warrants, or rights with respect to or interests in any such securities). Any decision by the recipient to buy or to sell should be based on publicly available information on the related security and, where appropriate, should take into account the content of the related prospectus filed with and available from the entity governing the related market and the company issuing the security. This report is issued in Spain by Santander Central Hispano Bolsa, Sociedad de Valores, S.A. (SCH Bolsa), and in the United Kingdom by Santander Central Hispano S.A., London Branch (Santander London), which is regulated by the Financial Services Authority in the conduct of investment business in the UK. This report is not being issued to private customers. SCHI, Santander London, and SCH Bolsa are members of Grupo Santander. The following analysts hereby certify that their views about the companies and their securities discussed in this report are accurately expressed and that they have not received and will not receive direct or indirect compensation in exchange for expressing specific recommendations or views in this report: Luis Miranda. Grupo Santander receives non-investment banking revenue from the subject company. The information contained herein has been compiled from sources believed to be reliable, but, although all reasonable care has been taken to ensure that the information contained herein is not untrue or misleading, we make no representation that it is accurate or complete and it should not be relied upon as such. All opinions and estimates included herein constitute our judgment as at the date of this report and are subject to change without notice. Any U.S. recipient of this report (other than a registered broker-dealer or a bank acting in a broker-dealer capacity) that would like to effect any transaction in any security discussed herein should contact and place orders in the United States with SIS, which, without in any way limiting the foregoing, accepts responsibility (solely for purposes of and within the meaning of Rule 15a-6 under the U.S. Securities Exchange Act of 1934) for this report and its dissemination in the United States by Santander Investment Securities Inc. All Rights Reserved. 2005

CEMEX Cemex Increases its Offer for Rinker by 22%

CEMEX Cemex Increases its Offer for Rinker by 22% Latin American Equity Research Mexico City, April 10, 2007 Flashnote Mexico Cement & Construction CEMEX Cemex Increases its Offer for Rinker by 22% Gonzalo Fernandez* BUY Vivian Salomón* Mexico: Banco

More information

1Q05 Results Were Strong Overall and Better than Expected; Some Flags in Sigma

1Q05 Results Were Strong Overall and Better than Expected; Some Flags in Sigma Latin American Equity Research Mexico, April 21, 2005. Earnings Comment Mexico Conglomerates ALFA (US$4.71) (ALFAA) STRONG BUY TARGET PRICE: US$6.15 1Q05 Results Were Strong Overall and Better than Expected;

More information

Latin American Equity Research. Mr. F. Chico to Tender for 42.65% of Asur Shares at M$56.00

Latin American Equity Research. Mr. F. Chico to Tender for 42.65% of Asur Shares at M$56.00 Latin American Equity Research Mexico City, March 30, 2007 Flashnote Mexico Airports ASUR Mr. F. Chico to Tender for 42.65% of Asur Shares at M$56.00 BUY Gonzalo Fernández* Vivian Salomón* Mexico: Banco

More information

KIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold

KIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold Latin American Equity Research Mexico City, November 20, 2006 KIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold Joaquín Ley* Mexico: Santander Banco Santander S.A. 5255) 5269-1921 jley@santander.com.mx

More information

Infonavit Announces its Financial Plan

Infonavit Announces its Financial Plan Latin American Equity Research Mexico City, November 28, 2007 Sector Report Mexico Cement & Construction HOUSING REVIEW NOVEMBER 2007 Infonavit Announces its 2008-2012 Financial Plan Gonzalo Fernández*

More information

WALMEX HOLD. Have You Looked at P/BV? (12/14/05) CURRENT PRICE: US$5.81/M$62.35 TARGET PRICE: US$5.70/M$65.00

WALMEX HOLD. Have You Looked at P/BV? (12/14/05) CURRENT PRICE: US$5.81/M$62.35 TARGET PRICE: US$5.70/M$65.00 Latin American Equity Research Mexico City, December 15, 2005 WALMEX Have You Looked at P/BV? Company Report Mexico Retail HOLD Joaquin Ley* Daniela M. Bretthauer* Mexico: Banco Santander Serfin, S.A Brazil:

More information

MEXICAN AIRPORTS EARNINGS PREVIEW

MEXICAN AIRPORTS EARNINGS PREVIEW Latin American Equity Research Mexico City, April 20, 2009 Sector Preview Mexico Aerospace & Transportation MEXICAN AIRPORTS EARNINGS PREVIEW A Tough 1Q09, Driven by Weak Passenger Figures Luis Miranda,

More information

CEMEX (US$24.03) Positive 3Q03 Operating Results and Advances on the Financial Front TARGET PRICE: US$27.00

CEMEX (US$24.03) Positive 3Q03 Operating Results and Advances on the Financial Front TARGET PRICE: US$27.00 Latin America Quarterly Earnings Report CEMEX (US$24.03) (CX) Mexico Cement & Construction Mexico City, October 9, 2003 U.S. investors inquiries should be directed to Santander Central Hispano Investment

More information

ICA BUY. ICA Reloaded: Setting 2004 Target, Upgrading to Buy (12/23/03) CURRENT PRICE: US$1.41/M$2.58 TARGET PRICE: US$1.75/M$3.30

ICA BUY. ICA Reloaded: Setting 2004 Target, Upgrading to Buy (12/23/03) CURRENT PRICE: US$1.41/M$2.58 TARGET PRICE: US$1.75/M$3.30 Latin American Equity Research ICA Mexico Cement & Construction Mexico City, December 26, 2003 ICA Reloaded: Setting 2004 Target, Upgrading to Buy Gonzalo Fernández (5255) 5269-1931 gofernandez@santander.com.mx

More information

Growth Opportunities Remain Intact, Introducing YE2011 Target Price

Growth Opportunities Remain Intact, Introducing YE2011 Target Price Latin American Equity Research Mexico City, August 2, 2010 Company Report Mexico Healthcare GENOMMA LAB Growth Opportunities Remain Intact, Introducing YE2011 Target Price Joaquin Ley* BUY Daniel Gewehr*

More information

GRUPO AEROPORTUARIO DEL PACIFICO HOLD. Reaches Cruising Altitude; Downgrading to Hold

GRUPO AEROPORTUARIO DEL PACIFICO HOLD. Reaches Cruising Altitude; Downgrading to Hold Latin American Equity Research Mexico City, December 1, 2006 Company Report Mexico Airports GRUPO AEROPORTUARIO DEL PACIFICO Reaches Cruising Altitude; Downgrading to Hold Gonzalo Fernandez* HOLD Vivian

More information

Still Robust Top-Line Growth to Offset Infrastructural Build-Out. Alexander Robarts Joaquin Ley* Alonso Aramburu

Still Robust Top-Line Growth to Offset Infrastructural Build-Out. Alexander Robarts Joaquin Ley* Alonso Aramburu Latin American Equity Research New York, July 11, 2006 Company Report Mexico Food GRUMA Still Robust Top-Line Growth to Offset Infrastructural Build-Out BUY Alexander Robarts Joaquin Ley* Alonso Aramburu

More information

Latin American Equity Research

Latin American Equity Research Latin American Equity Research New York, July 13, 2009 Sector Report Latam Mining MIND THE GAP Worst Case Has Limited Downside Potential GMEXICO VS. PCU Luis Miranda*, CFA Victoria Santaella Alonso Aramburu

More information

(5255) (5255)

(5255) (5255) Latin American Equity Research Mexico City, February 24, 2009 WALMEX For Those About to Buy, We Salute You Upgrading to Buy Joaquin Ley* Company Update Mexico Retail BUY Roberto Liaño* Mexico: Banco Santander

More information

MEXICO TMT SECTOR JANUARY 2011

MEXICO TMT SECTOR JANUARY 2011 Latin American Equity Research Mexico City, January 31, 2011 Sector Preview Mexico Telecom, Media & Technology MEXICO TMT SECTOR JANUARY 2011 Post-Cancun Update and 4Q10 Previews Gregorio Tomassi*, CFA

More information

Acquisitions Appear Priced In; Downgrading on Valuation vs. Global Peers (212) (212)

Acquisitions Appear Priced In; Downgrading on Valuation vs. Global Peers (212) (212) Latin American Equity Research New York, June 9, 2008 COCA-COLA FEMSA Company Update Mexico Beverages UNDERPERFORM Acquisitions Appear Priced In; Downgrading on Valuation vs. Global Peers Alexander Robarts

More information

3,951 EBITDA 1,174 1,153 1,260 1,284 1,332 Outst shares (mn) 57 EBIT Free float (%)

3,951 EBITDA 1,174 1,153 1,260 1,284 1,332 Outst shares (mn) 57 EBIT Free float (%) European Equity Research ACCIONA Facing a Good 2017E Spain Electricity November 7, 2016 (07:15 CET) BUY CURRENT PRICE: 69.01 TARGET PRICE: 82.40 ANA released 9M16 results on Nov 4 and we have adjusted

More information

GENOMMA LAB BUY. A Prescription for Growth; Increasing YE2010 Target Price (9/28/09) CURRENT PRICE: M$17.46/US$1.29 TARGET PRICE: M$30.00/US$2.

GENOMMA LAB BUY. A Prescription for Growth; Increasing YE2010 Target Price (9/28/09) CURRENT PRICE: M$17.46/US$1.29 TARGET PRICE: M$30.00/US$2. Latin American Equity Research Mexico City, October 1, 2009 Company Update Mexico Health Care GENOMMA LAB A Prescription for Growth; Increasing YE2010 Target Price BUY Joaquin Ley* Daniel Gewehr* Roberto

More information

More Growth Ahead at an Attractive Valuation: Raising Target Price

More Growth Ahead at an Attractive Valuation: Raising Target Price Latin American Equity Research New York, November 22, 2010 Company Report Mexico Mining GRUPO MEXICO More Growth Ahead at an Attractive Valuation: Raising Target Price Victoria Santaella BUY Sergio Matsumoto

More information

AMX AND TMX OCTOBER 2010

AMX AND TMX OCTOBER 2010 Latin American Equity Research Mexico City, October 26, 2010 Sector Report Mexico Telecom & Media AMX AND TMX OCTOBER 2010 No Bargains; Introducing YE2011 Target Prices; Revising Ratings Gregorio Tomassi*,

More information

CEMEX HOLD (2/17/09) CURRENT PRICE: US$7.05/M$10.50 TARGET PRICE: US$8.00/M$11.00

CEMEX HOLD (2/17/09) CURRENT PRICE: US$7.05/M$10.50 TARGET PRICE: US$8.00/M$11.00 Latin American Equity Research Mexico City, February 17, 2009 CEMEX Company Report Mexico Cement & Construction The Long and Winding Road Lowering Target and Reiterating Hold Gonzalo Fernández* Mexico:

More information

Templeton Latin America Fund A (Ydis) USD

Templeton Latin America Fund A (Ydis) USD Templeton Latin America Fund A (Ydis) USD Franklin Templeton Investment Funds Fund Manager Report Value Equity Product Details 1 Fund Assets $1,050,576,208.81 Fund Inception Date 28/02/1991 Number of Issuers

More information

RASSINI Automotive Industry

RASSINI Automotive Industry RASSINI Market Outperformer 12M FWD Price Target P$49.0 Price 43.31 12M Price Range 28.8 / 39.4 Shares Outstanding 320 Market Cap (Mill) 13,865 Float 30.0% Net Debt (Mill) 1,867 EV (Mill) 16,345 Dividend

More information

AIRPORT REVIEW JANUARY 2009 Turbulence Remains Keep Your Seatbelts Fastened

AIRPORT REVIEW JANUARY 2009 Turbulence Remains Keep Your Seatbelts Fastened Latin American Equity Research Assumption of Coverage Mexico City, January 6, 2009 Mexico Aerospace & Transportation AIRPORT REVIEW JANUARY 2009 Turbulence Remains Keep Your Seatbelts Fastened Luis Miranda*,

More information

2Q16 Highlights: 12M FWD EV/EBITDA 12M PRICE PERFORMANCE VS. IPC P/E

2Q16 Highlights: 12M FWD EV/EBITDA 12M PRICE PERFORMANCE VS. IPC P/E GISSA Market Outperformer 12M FWD Price Target P$45.0 Price 31.4 12M Price Range 29.5/ 33.09 Shares Outstanding 356 Market Cap (Mill) 11,169 Float 19.5% Net Debt (Mill) 46 EV (Mill) 11,164 Dividend Yield

More information

CEMEX Cement. Quarterly Report February 9, CEMEX remains on track to regain its investment grade.

CEMEX Cement. Quarterly Report February 9, CEMEX remains on track to regain its investment grade. Quarterly Report CEMEX Market Outperformer 2017 Price Target US$11.0 Price 8.9 12M Price Range 4.1/9.5 Shares Outstanding (Mill)* 1,545 Market Cap USD (Mill) 13,797 Float 78.6% Net Debt USD (Mill)** 12,516

More information

CEMEX Cement. Quarterly Report July 27, CX: Proving the success of its Value-before-Volume strategy.

CEMEX Cement. Quarterly Report July 27, CX: Proving the success of its Value-before-Volume strategy. Quarterly Report CEMEX Market Outperformer 12M FWD Price Target US$10.8 Price 7.1 12M Price Range 3.8/8.6 Shares Outstanding (Mill)* 1,542 Market Cap USD (Mill) 10,976 Float 78.6% Net Debt USD (Mill)**

More information

Templeton Latin America Fund A (Ydis) USD

Templeton Latin America Fund A (Ydis) USD Templeton Latin America Fund A (Ydis) USD Franklin Templeton Investment Funds Fund Manager Report Value Equity Product Details 1 Fund Assets $969558829.19 Fund Inception Date 28/02/1991 Number of Issuers

More information

FLASH NOTE Welspun India 31 Jan 17

FLASH NOTE Welspun India 31 Jan 17 Oct-11 Feb-12 Jun-12 Oct-12 Feb-13 Jun-13 Oct-13 Feb-14 Jun-14 Oct-14 Feb-15 Jun-15 Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 FLASH NOTE Welspun India 31 Jan 17 CMP (Rs) 76 TP (Rs) 81 Outperformer Key Figures

More information

A Key Regional Player in the Making: Initiating Coverage with a Buy Rating

A Key Regional Player in the Making: Initiating Coverage with a Buy Rating Latin American Equity Research Mexico City, December 4, 2007 MEXICHEM Company Report Mexico Chemicals * Employed by a non-us affiliate of Santander Investment Securities, Inc. and is not registered/qualified

More information

VITRO Conglomerates. Quarterly Report July 29, VITRO Market Outperformer 12M FWD Price Target P$73.0

VITRO Conglomerates. Quarterly Report July 29, VITRO Market Outperformer 12M FWD Price Target P$73.0 Quarterly Report VITRO Market Outperformer 12M FWD Price Target P$73.0 Price 61.1 12M Price Range 36.3/ 66.7 Shares Outstanding (Mill) 483.6 Market Cap (Mill) 1,564 Float 20% Net Debt ( Mill) -424 EV Adj.

More information

Mahindra and Mahindra Maintain Outperformer. (Rs mn) Mar 14 Mar 15 YoY (%) Dec 14 QoQ (%) FY14 FY15P YoY (%) FY16E YoY (%) FY17E YoY (%)

Mahindra and Mahindra Maintain Outperformer. (Rs mn) Mar 14 Mar 15 YoY (%) Dec 14 QoQ (%) FY14 FY15P YoY (%) FY16E YoY (%) FY17E YoY (%) Batlivala & Karani RESULT UPDATE Mahindra and Mahindra Maintain Outperformer LARGE CAP Share Data Reuters code Bloomberg code MAHM.BO MM IN Market cap. (US$ mn) 12,243 6M avg. daily turnover (US$ mn) 21.0

More information

Q4 EARNINGS REPORT Welspun India 25 Apr 17

Q4 EARNINGS REPORT Welspun India 25 Apr 17 Dec-11 Apr-12 Aug-12 Dec-12 Apr-13 Aug-13 Dec-13 Apr-14 Aug-14 Dec-14 Apr-15 Aug-15 Dec-15 Apr-16 Aug-16 Dec-16 Q4 EARNINGS REPORT Welspun India 25 Apr 17 CMP (Rs) 94 TP (Rs) 112 Maintain Outperformer

More information

Darden Restaurants, Inc.

Darden Restaurants, Inc. Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Cytori Therapeutics (CYTX - $ 2.32) BARDA Decision is a Major Positive Development Yesterday, CYTX

More information

Grupo Sura. Equity Research. 4Q14: FX distorts a continuation of good operating trends

Grupo Sura. Equity Research. 4Q14: FX distorts a continuation of good operating trends Equity Research Grupo Sura 4Q14: FX distorts a continuation of good operating trends Operating lines beat us (again), but FX losses hit bottom line (as expected) Sura s 4Q14 insurance and asset management

More information

LARGE CAP & 1,970 BSE

LARGE CAP & 1,970 BSE Batlivala & Karani RESULT UPDATE LARGE CAP Share Data Reuters code DIVI.BO Bloomberg code DIVI IN Market cap. (US$ mn) 4,97 6M avg. daily turnover (US$ mn) 4.7 Issued shares (mn) 133 Target price (Rs)

More information

Rajesh Exports. Wednesday, July 29, Target Price Rs Current Price Rs Upside Potential 66%

Rajesh Exports. Wednesday, July 29, Target Price Rs Current Price Rs Upside Potential 66% Wednesday, July 29, 2015 www.evaluateresearch.com Target Price Rs. 800.00 Current Price Rs. 482.20 Upside Potential 66% Market Cap. Shares Outstanding Rs. 142,400mn $ 2.2bn 295mn Free Float (FF %) 77mn

More information

CVC. Equity Research. Another solid sales showing. Latin America Retailing Company Note 07 April 2015

CVC. Equity Research. Another solid sales showing. Latin America Retailing Company Note 07 April 2015 Equity Research CVC Another solid sales showing Promotional environment drove sales in Q1 Bookings rose 11% y/y to R$1.269bn, supported by 6.4% SSS and the opening of 105 stores (totaling 919 exclusive

More information

The Reasons Why OSK Holds the Title of Top Pick

The Reasons Why OSK Holds the Title of Top Pick Osisko Mining (OSK-T: C$4.20) November 26, 2013 BUY, High Risk, Top Pick Dundee target: C$7.00 Joseph Fazzini, CPA, CA, CFA / (647) 428-8248 jfazzini@dundeecapitalmarkets.com The Reasons Why OSK Holds

More information

Embraer. Equity Research. Order from Japan Airlines. Latin America Capital Goods Company Note 28 August 2014

Embraer. Equity Research. Order from Japan Airlines. Latin America Capital Goods Company Note 28 August 2014 Equity Research Order from Japan Airlines New order from Japan Airlines; potential split with Mitsubishi Japan Airlines (JAL) has signed a firm order with ERJ for 15 E-Jets (E170 and E190 models) totaling

More information

Enbridge Energy Partners, L.P.

Enbridge Energy Partners, L.P. Equity Research Earnings Update April 30, 2007 Stock Rating: Sector Performer Sector Weighting: Market Weight 12-18 mo. Price Target $60.00 EEP-NYSE (4/27/07) $61.19 Key Indices: None 3-5-Yr. EPS Gr. Rate

More information

Almarai Steady performance

Almarai Steady performance RSI10 ALMARAI AB: Saudi Arabia Rating Target price Current price NEUTRAL SAR55.05 (-4.59% upside) SAR57.66 Key themes & implications Almarai reported a positive top-line in Q1 2016, showing resilience

More information

Templeton Latin America Fund A (Ydis) USD

Templeton Latin America Fund A (Ydis) USD Templeton Latin America Fund A (Ydis) USD Franklin Templeton Investment Funds Fund Manager Report Blend Equity Product Details 1 Fund Assets $1,076,825,961.83 Fund Inception Date 28/02/1991 Number of Issuers

More information

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016 EQUITY RESEARCH QUARTERLY UPDATE September 22, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $900.00 AZO - NYSE $751.45 3-5 Yr. EPS Gr. Rate 14% 52-Wk Range $819.54-$681.01 Shares Outstanding 30.8M

More information

Coca Cola FEMSA (KOF)

Coca Cola FEMSA (KOF) Mexico and Brazil posted good results, and fully offset the decreases in Central America and Venezuela. Mexico has not slowed down its growth rate. Both prices and volumes performed positively. Brazil

More information

China Renewable Energy Investment Ltd (987_HK)

China Renewable Energy Investment Ltd (987_HK) Wednesday, March 21, 2018 www.evaluateresearch.com Target Price HK$ 0.50 Current Price HK$ 0.23 Upside Potential 117% Market Cap. Shares Outstanding HK$ 525 mn $ 66.90 mn 2,364.7 mn Free Float (FF %) 631.9

More information

Figure 1 SAFCO Q1 results Q Q Q (SAR mn) Operating profit % 375.6% 347. Operating margin 47% 8% 30% 40%

Figure 1 SAFCO Q1 results Q Q Q (SAR mn) Operating profit % 375.6% 347. Operating margin 47% 8% 30% 40% Vol mn RSI10 SAFCO Petrochemicals Industrial SAFCO AB: Saudi Arabia US$7.22bn 40% US$5.60mn Market cap Free float Avg. daily volume Target price 62.00-2.6% over current Current price 63.70 as at 8/5/2018

More information

GFAMSA Retail. Quarterly Report July 29, GFAMSA Market Performer 12M FWD Price Target P$8.6

GFAMSA Retail. Quarterly Report July 29, GFAMSA Market Performer 12M FWD Price Target P$8.6 Quarterly Report GFAMSA Market Performer 12M FWD Price Target P$8.6 Price 7.8 12M Price Range 6.77 / 15.34 Shares Outstanding (Mill) 562 Market Cap (Mill) 4,383 Float 36% Net Debt (Mill) 27,728 EV (Mill)

More information

Notes Linked to the S&P Economic Cycle Factor Rotator Index due April 30, 2025

Notes Linked to the S&P Economic Cycle Factor Rotator Index due April 30, 2025 The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities

More information

CENTENE CORP. Read-Thru From NY Governor s Budget to Fidelis Deal HEALTHCARE SERVICES. (CNC $ Peer Perform)

CENTENE CORP. Read-Thru From NY Governor s Budget to Fidelis Deal HEALTHCARE SERVICES. (CNC $ Peer Perform) HEALTHCARE SERVICES Managed Care Market Overweight CENTENE CORP (CNC $110.80 Peer Perform) Read-Thru From NY Governor s Budget to Fidelis Deal NY Governor s Budget Could Impact Fidelis Deal On 1/16/18

More information

Rajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer

Rajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer Monday, February 4, 2019 www.evaluateresearch.com Target Price Rs. 900.00 Current Price Rs. 598.00 Upside Potential 50% Market Cap. Shares Outstanding Rs. 176,802 mn US$ 2.47 bn 295.3 mn Free Float (FF

More information

Copel. Equity Research. Big boost from Araucária. Latin America Electric & Other Utilities Company Note 15 May 2015

Copel. Equity Research. Big boost from Araucária. Latin America Electric & Other Utilities Company Note 15 May 2015 Equity Research Big boost from Araucária Strong quarter reported much stronger-than-expected figures. Similar to most of the companies that reported, part of the outperformance comes from an energy allocation

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Emergent BioSolutions (EBS - $34.89) Another Acquisition in EBS s Wheelhouse, 2020 Topline $1B Goal in Sight Yesterday

More information

[Please refer to Appendix. Sherwin-Williams Co. (SHW) High-Quality Beat Positive for Shares RESEARCH UPDATE

[Please refer to Appendix. Sherwin-Williams Co. (SHW) High-Quality Beat Positive for Shares RESEARCH UPDATE April 21, 2016 Baird Equity Research Packaging & Coatings Sherwin-Williams Co. (SHW) High-Quality Beat Positive for Shares Strong start to 2016 led by core sales. We believe that the shares of Sherwin-Williams

More information

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research Exports remain subdued, outlook better November 08, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs850 Target Price Rs957 Implied Upside 12.6% Sensex 27,591 Nifty 8,544 (Prices

More information

BTO: Q2/15 Earnings Preview

BTO: Q2/15 Earnings Preview B2Gold Corp. (BTO-T: C$1.69), (BTG-N: US$1.31) August 13, 2015 BUY, High Risk Dundee target: C$2.75 BTO: Q2/15 Earnings Preview Joseph Fazzini, CPA, CA, CFA / (647) 428-8248 jfazzini@dundeecapitalmarkets.com

More information

Raising EPS, Setting 2018 Targets

Raising EPS, Setting 2018 Targets November 17, 2017 05:01 AM GMT Argentina Financial Institutions Raising EPS, Setting 2018 Targets We are updating EPS estimates on the back of 3Q17 results, and setting 2018 price targets. We see ~15%

More information

Shenhua Reuters: 1088.HK, Bloomberg: 1088 HK; YCM Reuters: 1171.HK, Bloomberg: 1171 HK

Shenhua Reuters: 1088.HK, Bloomberg: 1088 HK; YCM Reuters: 1171.HK, Bloomberg: 1171 HK 20 December 20 China Coal Market Decelerating production growth Firm spot coal prices expected in 2006: China s coal production in November only grew by 3.1% Y/Y, highlighting the production disruption

More information

Record Low Costs At Santander Lead To Q1 Earnings Beat

Record Low Costs At Santander Lead To Q1 Earnings Beat Trevali Mining Corp. (TV-T: C$0.49) May 12, 2016 BUY, High Risk, Top Pick Dundee target: C$1.00 Joseph Gallucci, MBA / (514) 396-0330 jgallucci@dundeecapitalmarkets.com Ian Bjornson, B.Eng / (514) 396-0325

More information

THE MEXICO EQUITY & INCOME FUND, INC.

THE MEXICO EQUITY & INCOME FUND, INC. RETURNS As of June 30, 2017 Total Annual Average U.S. Dollar Return through June 30, 2017 (Reinvested Dividends) 1 Month YTD 1 Year 3 Years 5 Years 10 Years Since MXE Inception in 08/30/90 MXE NAV* 5.74%

More information

BUY. Suprajit Engineering (SEL) Automobiles

BUY. Suprajit Engineering (SEL) Automobiles Suprajit Engineering (SEL) Automobiles Strong performance. Suprajit Engineering reported a consolidated net profit of `210 mn in 3QFY16, which was 2% higher than our estimates. Phoenix Lamps was consolidated

More information

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit EQUITY RESEARCH QUARTERLY UPDATE July 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $300.00 ORLY - NASDAQ $277.51 3-5 Yr. EPS Gr. Rate 18% 52-Wk Range $284.66-$225.12 Shares Outstanding 99.4M

More information

Table 1. Sum-of-the-parts valuation. EPS Growth

Table 1. Sum-of-the-parts valuation. EPS Growth (001120) Solid 4Q, excluding one-offs (LGI) yesterday reported that its consolidated sales rose 3.8% q-q to KRW3.8t in 4Q, but that its operating profit plunged 98% q-q to KRW600m with a net loss of KRW237.2b,

More information

Q4 Preview & Transfer of Coverage: Growth Potential and Attractive Valuation Supports Strong Buy

Q4 Preview & Transfer of Coverage: Growth Potential and Attractive Valuation Supports Strong Buy 23-Apr-14 14-May-14 4-Jun-14 25-Jun-14 16-Jul-14 6-Aug-14 27-Aug-14 17-Sep-14 8-Oct-14 29-Oct-14 19-Nov-14 10-Dec-14 31-Dec-14 21-Jan-15 11-Feb-15 4-Mar-15 25-Mar-15 15-Apr-15 Daily Volume ('000) Share

More information

CSCK 12. Credit Suisse Mexico Credit Opportunities Trust January Overview. Investment Performance

CSCK 12. Credit Suisse Mexico Credit Opportunities Trust January Overview. Investment Performance CSCK 12 Credit Suisse Mexico Credit Opportunities Trust January 2019 This document is for information purposes only. The information contained herein is public, comes from public sources or is informative

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 7, 2018 Alimera Sciences (ALIM - $1.09) Quarter Mostly in-line, 2019 could Benefit from Repeat Usage ALIM

More information

Tullett Prebon (LSE: TLPR LN)

Tullett Prebon (LSE: TLPR LN) December 1, 2008 Financial Services Market Structure & Trading United Kingdom Company Update Rating: Price: Price Target: Bloomberg: BUY 150p 260p LSE: TLPR LN Market Data 52-Week Range: 540p-125p Total

More information

Marcopolo. Equity Research. Q1 beat our lowered forecasts; strong exports from Brazil. Brazil Transportation Company Note 04 May 2015

Marcopolo. Equity Research. Q1 beat our lowered forecasts; strong exports from Brazil. Brazil Transportation Company Note 04 May 2015 Equity Research Marcopolo Q1 beat our lowered forecasts; strong exports from Brazil Results were weak again, but above our call; EPS fell 37% y/y POMO posted a poor set of Q1 results (albeit better-than-expected),

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 8, 2018 Viking Therapeutics (VKTX - $13.74) 3Q18: Conference Call Uneventful with Investor Focus on the Design

More information

LoopNet. $28 $26 $24 $22 $20 $18 $16 $14 $12 $10 Jun-06 Sep-06 Dec-06 Mar-07 Jun-07

LoopNet. $28 $26 $24 $22 $20 $18 $16 $14 $12 $10 Jun-06 Sep-06 Dec-06 Mar-07 Jun-07 July 31, 2007 Analyst Highlights Street Estimates Recommendation: BUY 2006A 2007E 2008E Current Price: $21.01 EPS $0.40 $0.48 $0.59 Target Price: $25.00 P/E 52.5 43.8 35.6 Forecast Stock Return: 19.0%

More information

Advanced Petrochemicals Co Upgrade to OW. Raise TP to SAR61/share

Advanced Petrochemicals Co Upgrade to OW. Raise TP to SAR61/share Vol mn RSI10 Petrochemicals Industrial APPC AB: Saudi Arabia US$2.891bn 9% US$2.792mn Market cap Free float Avg. daily volume Target price 61.00 10.7% over current Current price 55.10 as at 5/7/2018 Neutral

More information

Suzano Papel e Celulose

Suzano Papel e Celulose Equity Research Transgenic clones: the next big leap for pulp? Approval to commercially exploit GM clones is a LT driver of competiveness Suzano announced today that it received an initial approval from

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.56) Rivipansel (GMI-1070) in Resolving Vaso-occlusive Crisis (VOC) of

More information

Canada Bread Acquisition February 12, 2014

Canada Bread Acquisition February 12, 2014 Canada Bread Acquisition February, 04 Transaction Overview A unique and sizable opportunity to enter the Canadian baking market - Annual Revenues: CAN$,439 million - Annual EBITDA: CAN$85 million (.9%

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.80) Iluvien sales continue their slow & steady growth ALIM reported 1Q16 roughly in-line

More information

GOING EAST & ONE YEAR AFTER

GOING EAST & ONE YEAR AFTER Givaudan Chemicals Neutral Fair Value CHF1050.00 2007-11-22 Price CHF1044.00 (Closing price as of 2007-11-21) Applied disclosures can be found in the appendix Price and rel. Performance GOING EAST & ONE

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.07) Impressive Ex-US Sales Help ALIM Exceed Topline Expectations. ALIM recently announced

More information

ECONOMICS July 18, 2016 BRAZIL Credit Market

ECONOMICS July 18, 2016 BRAZIL Credit Market Dec-3 Jan-2 Aug-2 Mar-3 Oct-3 May- Jul- Feb-6 Sep-6 Apr-7 Nov-7 Jan-9 Aug-9 Mar- Oct- May-11 Jul-12 Feb-13 Sep-13 Apr-1 Nov-1 Jan-16 ECONOMICS July 18, 16 BRAZIL Credit Market What Can Credit Do for Brazilian

More information

Eldorado. Fixed Income Research BTG Pactual Global Research. Weak Q3 on pulp/fx; despite attractive carry, overhangs remain

Eldorado. Fixed Income Research BTG Pactual Global Research. Weak Q3 on pulp/fx; despite attractive carry, overhangs remain Fixed Income Research BTG Pactual Global Research Eldorado Brazil Paper Products FixedIncome 25 October 2016 Weak Q3 on pulp/fx; despite attractive carry, overhangs remain EBITDA down 43% y/y on unfavorable

More information

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2, : price: EPS: How does our one year outlook change? We maintain our negative stance on SKF India due to the absence of significant growth momentum drivers over the medium term. While railways could be

More information

Indra. Hold July 2009 LAST PRICE CHANGE IN RECOMMENDATION

Indra. Hold July 2009 LAST PRICE CHANGE IN RECOMMENDATION 20 July 2009 Indra LAST PRICE Hold 15.95 CHANGE IN RECOMMENDATION Bloomberg IDR SM Reuters IDR.MC Share price Target price 15.95 17.05 Market Cap N. Shares 2.68bn 164.1m Main Shareholders CajaMadrid 19.8%

More information

Preparing the soil. Recommendation and investment thesis

Preparing the soil. Recommendation and investment thesis SQM-B Target price: CLP 32,300 Recommendation: Hold Risk: Medium June 21 st, 2011 Sector: Mining Update report Analyst: Camila Pindar Preparing the soil Recommendation and investment thesis SQM is the

More information

TERNIUM S.A. CONSOLIDATED FINANCIAL STATEMENTS As of December 31, 2006 and 2005 and for the years ended December 31, 2006, 2005 and 2004

TERNIUM S.A. CONSOLIDATED FINANCIAL STATEMENTS As of December 31, 2006 and 2005 and for the years ended December 31, 2006, 2005 and 2004 CONSOLIDATED FINANCIAL STATEMENTS As of December 31, 2006 and 2005 and for the years ended December 31, 2006, 2005 and 2004 46a, Avenue John F. Kennedy, 2 nd floor L 1855 R.C.S. Luxembourg : B 98 668 Index

More information

BM&F Bovespa. Equity Research. Weak May and World Cup ahead add more downside risk to. Latin America Financials - Non-banks Company Note 02 June 2014

BM&F Bovespa. Equity Research. Weak May and World Cup ahead add more downside risk to. Latin America Financials - Non-banks Company Note 02 June 2014 Equity Research Weak May and World Cup ahead add more downside risk to EPS After a slight improvement in April, volumes in May deteriorated again BM&FBovespa (BVMF) reported May operating data today, and

More information

Important information

Important information 26 April 2012 1 Important information 2 Banco Santander, S.A. ("Santander") cautions that this presentation contains forward-looking statements. These forward-looking statements are found in various places

More information

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview Equity Research Quick Bite Preview 22 October 2013 Air France-KLM Q3 due 31 October More restructuring needed Supported by lower fuel costs and the ramp up in cost savings, we expect Q3 to deliver a solid

More information

Asset Allocation Guide

Asset Allocation Guide JULY 2014 RBC WEALTH MANAGEMENT GLOBAL INSIGHT PERSPECTIVES FROM THE GLOBAL PORTFOLIO ADVISORY COMMITTEE Asset Allocation Guide In conjunction with the Global Insight publications, following is an updated

More information

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights AMBUJA S 4 MAY 2017 Quarterly Update HOLD Target Price: Rs 232 Margins to improve from Q2 Q1CY17standalone EBITDA at Rs 4.0 bn was in line withconsensus estimate.volume was up 3% YoY to 6 mnt. Realization

More information

Bradesco. Equity Research. Buys HSBC Brasil for R$17.6bn, or 1.6x P/BV14. Good strategic fit at a higher-than-expected cost

Bradesco. Equity Research. Buys HSBC Brasil for R$17.6bn, or 1.6x P/BV14. Good strategic fit at a higher-than-expected cost Buys HSBC Brasil for R$17.6bn, or 1.6x P/BV14. Good strategic fit at a higher-than-expected cost 100% of HSBC's operations in Brazil; small EPS impact but Tier 1 down 280bps Bradesco announced earlier

More information

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1 [ Result Update Equity India Forging & Industrials Bharat Forge Ltd. No Respite in Sight May 29, 2013 CMP (`) Target (`) 241 238 Potential Upside Absolute Rating (1.24)% HOLD Market Info (as on May 28,

More information

City of London Investment Group*

City of London Investment Group* For FCA purposes this is a Marketing Communication City of London Investment Group* CLIG LN Tough 1H trading update Financials What s new. CLIG s 1H trading update released this morning reveals details

More information

A (Ydis) EUR. Franklin Templeton Investment Funds. Fund Manager Report. Discrete Annual Performance (%) as at 31/01/2019. Calendar Year Returns (%)

A (Ydis) EUR. Franklin Templeton Investment Funds. Fund Manager Report. Discrete Annual Performance (%) as at 31/01/2019. Calendar Year Returns (%) Templeton Global Bond (Euro) Fund A (Ydis) EUR Franklin Templeton Investment Funds Fund Manager Report Unconstrained Fixed Income Product Details 1 Fund Assets 321879557.70 Fund Inception Date 29/08/2003

More information

Trinidad Drilling Ltd. (TDG-T; $8.90 intra-day) Rig Purchase/Sale Streamlines Ops; Moving to Strong Buy on Share Price Weakness

Trinidad Drilling Ltd. (TDG-T; $8.90 intra-day) Rig Purchase/Sale Streamlines Ops; Moving to Strong Buy on Share Price Weakness Special Situations Energy Services Trinidad Drilling Ltd. (TDG-T; $8.90 intra-day) Recommendation: Strong Buy Greg Colman, (416) 640-4890; gcolman@wwcm.com Alex MacDonald, P.Eng. (416) 640-5202; amacdonald@wwcm.com

More information

THE ROBO ADVISOR - EM EQUITIES

THE ROBO ADVISOR - EM EQUITIES THE ROBO ADVISOR - EM EQUITIES WHAT ROBO DOES: The Robo Advisor/EM Equities tool assigns valuation scores to nine EM markets under our scope, based on quantitative analyses and econometric models that

More information

Solid Q4 As EBITDA Ahead; But Corus Is A Transition Story & Our Focus Remains On F'17

Solid Q4 As EBITDA Ahead; But Corus Is A Transition Story & Our Focus Remains On F'17 I N S T I T U T I O N A L E Q U I T Y R E S E A R C H Robert Bek, CFA 1 (416) 594-7454 Bob.Bek@cibc.com Kulveer Grewal, CFA, CPA, CA 1 (416) 594-7907 Kulveer.Grewal@cibc.com j Corus Entertainment Inc.

More information

CIDMEGA Services. Outperformer 2 P$51.0. Quarterly Report October 25, CIDMEGA Market Outperformer 12m FWD Price Target P$51

CIDMEGA Services. Outperformer 2 P$51.0. Quarterly Report October 25, CIDMEGA Market Outperformer 12m FWD Price Target P$51 Quarterly Report October 25, 2016 CIDMEGA Market Outperformer 12m FWD Price Target P$51 Price 44.0 12M Price Range 37.5 / 50 Shares Outstanding 68 Market Cap (Mill) 2,976 Float 27% Net Debt (Mill) 1,823

More information

Q4/16 Results Support Our Thesis

Q4/16 Results Support Our Thesis I N S T I T U T I O N A L E Q U I T Y R E S E A R C H Robert Catellier, CFA 1 (416) 956-6197 Robert.Catellier@cibc.com Ollie Primak, CFA 1 (416) 956-6732 Ollie.Primak@cibc.com Ian Woodward, CFA 1 (416)

More information

SAFCO Q3: Margin beat as Urea price increases

SAFCO Q3: Margin beat as Urea price increases Vol mn RSI10 Petrochemicals Industrial AB: Saudi Arabia US$9.01bn 40% US$8.28mn Market cap Free float Avg. daily volume Target price 85.00 +4.8% over current Current price 81.10 as at 30/10/2018 Underweight

More information

LifeVantage Corp. NasdaqCM: LFVN

LifeVantage Corp. NasdaqCM: LFVN LifeVantage Corp. NasdaqCM: LFVN New Products and Valuation Outweigh issues in Japan, reiterate Strong Buy LifeVantage Corp (LFVN) focuses on selling healthy living products through direct selling. They

More information